Studies fatty liver disease in people with severe obesity considering weight-loss surgery
Compares fatty liver disease in adults with severe obesity who have or decline bariatric surgery.
Plain-language title generated from the registry record
Registry title: Prognostic Significance of Fatty Liver Disease in Bariatric Patients
Key facts
- Where
- Esbjerg, DenmarkSee the site
Where in Denmark
- Hospital of Southwest JutlandEsbjerg, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Esbjerg Hospital - University Hospital of Southern Denmark
- Trial code
- NCT03535142
- Record updated
- 5 March 2025
- Original description
Prospective non-randomized intervention case control study on patients with a BMI > 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.Read full original descriptionShow less
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
Prospective non-randomized intervention case control study on patients with a BMI > 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.
Inclusion: Age > 18 years; BMI >35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark; Able to give written informed consent; Age > 18 years; BMI >35 kg/m2 with no wish to undergo bariatric surgery; Able to give written informed consent.
Exclusion: Active viral hepatitis; Not willing or able to consent; Contraindications to liver biopsy.